97 related articles for article (PubMed ID: 10455407)
1. Cellular contaminants of adeno-associated virus vector stocks can enhance transduction.
Tenenbaum L; Hamdane M; Pouzet M; Avalosse B; Stathopoulos A; Jurysta F; Rosenbaum C; Hanemann CO; Levivier M; Velu T
Gene Ther; 1999 Jun; 6(6):1045-53. PubMed ID: 10455407
[TBL] [Abstract][Full Text] [Related]
2. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
3. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
4. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
5. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
6. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
7. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
Zhang X; Li CY
Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
[TBL] [Abstract][Full Text] [Related]
8. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
10. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
11. Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes.
Ulrich-Vinther M; Maloney MD; Goater JJ; Søballe K; Goldring MB; O'Keefe RJ; Schwarz EM
Arthritis Rheum; 2002 Aug; 46(8):2095-104. PubMed ID: 12209514
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR.
Mayginnes JP; Reed SE; Berg HG; Staley EM; Pintel DJ; Tullis GE
J Virol Methods; 2006 Nov; 137(2):193-204. PubMed ID: 16860883
[TBL] [Abstract][Full Text] [Related]
13. Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components.
Nakamura S; Nakamura R; Shibata K; Kobayashi M; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K; Kasahara N; Iwaki Y
Eur J Haematol; 2004 Oct; 73(4):285-94. PubMed ID: 15347316
[TBL] [Abstract][Full Text] [Related]
14. Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP-expression-switching system.
Ueno T; Matsumura H; Tanaka K; Iwasaki T; Ueno M; Fujinaga K; Asada K; Kato I
Biochem Biophys Res Commun; 2000 Jul; 273(2):473-8. PubMed ID: 10873630
[TBL] [Abstract][Full Text] [Related]
15. Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.
Koppold B; Sauer G; Büning H; Hallek M; Kreienberg R; Deissler H; Kurzeder C
Int J Oncol; 2005 Jan; 26(1):95-101. PubMed ID: 15586229
[TBL] [Abstract][Full Text] [Related]
16. In vivo gene delivery to articular chondrocytes mediated by an adeno-associated virus vector.
Ulrich-Vinther M; Duch MR; Søballe K; O'Keefe RJ; Schwarz EM; Pedersen FS
J Orthop Res; 2004 Jul; 22(4):726-34. PubMed ID: 15183427
[TBL] [Abstract][Full Text] [Related]
17. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
Clark KR; Voulgaropoulou F; Johnson PR
Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
[TBL] [Abstract][Full Text] [Related]
18. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectors.
Jiang S; Altmann A; Grimm D; Kleinschmidt JA; Schilling T; Germann C; Haberkorn U
Cancer Gene Ther; 2001 Jul; 8(7):469-72. PubMed ID: 11498767
[TBL] [Abstract][Full Text] [Related]
20. Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy.
Hörster A; Teichmann B; Hormes R; Grimm D; Kleinschmidt J; Sczakiel G
Gene Ther; 1999 Jul; 6(7):1231-8. PubMed ID: 10455431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
